Literature DB >> 9056541

Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease.

M L Maat-Schieman1, S G van Duinen, A J Rozemuller, J Haan, R A Roos.   

Abstract

Arterial and arteriolar amyloid-beta (A beta) deposition in hereditary cerebral hemorrhage with amyloidosis (Dutch) (HCHWA-D) and Alzheimer disease (AD) cerebral amyloid angiopathy (CAA) were studied as to morphology, extent, and association with mononuclear phagocyte system (MPS) cells using A beta, a-smooth muscle actin, and monocyte/macrophage marker (HLA-DR, CD68, CD11c, CD45) immunohistochemistry. The HCHWA-D/AD arterial/arteriolar media showed compact A beta deposits, first appearing at the media/adventitia junction, and concomitant smooth muscle loss. Only HCHWA-D CAA featured (a) severe involvement of larger arteries and (b) arterioles showing a single or double ring of radial A beta surrounding compact A beta. Radial A beta appeared to develop at the media/adventitia junction. Monocyte/macrophage marker-positive foci/cells co-localized with HCHWA-D arterial A beta. Focal HLA-DR/CD11c positivity was observed at the media/adventitia junction of AD/HCHWA-D arteries in the absence of local A beta, but not in controls. Monocyte/macrophage marker positivity co-localizing with radial A beta appeared continuous with perivascular cells and microglia clustering perivascularly. These results suggest that (a) MPS cells are topographically associated with HCHWA-D arterial A beta and radial arteriolar A beta, and (b) HLA-DR/CD11c immunoreactivity may appear at the media/adventitia junction prior to A beta. The latter finding and the assumed formation of radial A beta at the media/adventitia junction may relate to involvement of the abluminal basement membrane in CAA pathogenesis. The role of MPS cells in this process remains to be established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056541     DOI: 10.1097/00005072-199703000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.

Authors:  Jianting Miao; Feng Xu; Judianne Davis; Irene Otte-Höller; Marcel M Verbeek; William E Van Nostrand
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

3.  Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy.

Authors:  D T Winkler; L Bondolfi; M C Herzig; L Jann; M E Calhoun; K H Wiederhold; M Tolnay; M Staufenbiel; M Jucker
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

4.  CXC and CC chemokine receptors on coronary and brain endothelia.

Authors:  O Berger; X Gan; C Gujuluva; A R Burns; G Sulur; M Stins; D Way; M Witte; M Weinand; J Said; K S Kim; D Taub; M C Graves; M Fiala
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

5.  The potential role of amyloid beta in the pathogenesis of age-related macular degeneration.

Authors:  Takeshi Yoshida; Kyoko Ohno-Matsui; Shizuko Ichinose; Tetsuji Sato; Nobuhisa Iwata; Takaomi C Saido; Toshio Hisatomi; Manabu Mochizuki; Ikuo Morita
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

6.  Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.

Authors:  Jitika Rajpoot; Elliot J Crooks; Brandon A Irizarry; Ashley Amundson; William E Van Nostrand; Steven O Smith
Journal:  Biochemistry       Date:  2022-06-06       Impact factor: 3.321

7.  β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy.

Authors:  Ellis S van Etten; Marcel M Verbeek; Jeroen van der Grond; Ronald Zielman; Sanneke van Rooden; Erik W van Zwet; Anna M van Opstal; Joost Haan; Steven M Greenberg; Mark A van Buchem; Marieke J H Wermer; Gisela M Terwindt
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

Review 8.  The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application.

Authors:  Yinghan Guo; Hanhai Zeng; Chen Gao
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

9.  Amyloid-β peptide on sialyl-Lewis(X)-selectin-mediated membrane tether mechanics at the cerebral endothelial cell surface.

Authors:  Sholpan Askarova; Zhe Sun; Grace Y Sun; Gerald A Meininger; James C-M Lee
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.

Authors:  Edward K Agyare; Kristen M Jaruszewski; Geoffry L Curran; Jens T Rosenberg; Samuel C Grant; Val J Lowe; Subramanian Ramakrishnan; Anant K Paravastu; Joseph F Poduslo; Karunya K Kandimalla
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.